Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome

Journal of Surgical Oncology

Volumn 99, Issue 7, 2009, Pages 439-446

  Schiffer, Eduardo ^a   Frossard, Jean Louis ^a   Rubbia Brandt, Laura ^a   Mentha, Gilles ^a   Pastor, Catherine M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Chemotherapy; Colorectal carcinoma; Hepatic regeneration; Sinusoidal obstruction syndrome

Indexed keywords

KI 67 ANTIGEN; MONOCROTALINE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DISEASE SEVERITY; LIVER FUNCTION; LIVER INJURY; LIVER REGENERATION; LIVER RESECTION; LIVER SINUSOID; LIVER TOXICITY; MICROCIRCULATION; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SINUSOIDAL OBSTRUCTION SYNDROME;

ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; HEPATECTOMY; HEPATIC VENO-OCCLUSIVE DISEASE; LIVER REGENERATION; MONOCROTALINE; ORGANOPLATINUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 66349093716     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21276     Document Type: Article

References (39)

1. Stangl R, Altendorf-Hofmann A, Charnley RM, et al.: Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-1410. (Pubitemid 24167517)
2. Abdalla EK, Adam R, Bilchik AJ, et al.: Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006;13:1271-1280. (Pubitemid 44435793)
3. Minagawa M, Makuuchi M, Torzilli G, et al.: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 2000;231:487-499. (Pubitemid 30185854)
4. Andres A, Majno PE, Morel P, et al.: Improved long-term outcome of surgery for advanced colorectal liver metastases: Reasons and implications for management on the basis of a severity score. Ann Surg Oncol 2008;15:134-143.
5. Bismuth H, Adam R, Lévi F, et al.: Resection of nonresectable liver metastases fro colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-522. (Pubitemid 26337559)
6. Mathijssen RH, van Alphen RJ, Verweij J, et al.: Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res 2001;7:2182-2194. (Pubitemid 32751614)
7. Carrato A, Gallego J, Diaz-Rubio E: Oxaliplatin: Results in colorectal carcinoma. Crit Rev Oncol Hematol 2002;44:29-44. (Pubitemid 35203237)
8. Misset JL, Bleiberg H, Sutherland W, et al.: Oxaliplatin clinical activity: A review. Crit Rev Oncol Hematol 2000;35:75-93. (Pubitemid 30599431)
9. Schmoll HJ: The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: Prospects and future directions. Semin Oncol 2002;29:34-39. (Pubitemid 35191039)
10. Falcone A, Masi G, Allegrini G, et al.: Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer. J Clin Oncol 2002;20:4006-4014.
11. Mentha G, Majno PE, Andres A, et al.: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006;93:872-878. (Pubitemid 44035261)
12. Vauthey JN, Pawlik TM, Ribero D, et al.: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-2072. (Pubitemid 46622116)
13. Rubbia-Brandt L, Giostra E, Brezault C, et al.: Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007;18:299-304. (Pubitemid 46323097)
14. Rubbia-Brandt L, Audard V, Sartoretti P, et al.: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-466. (Pubitemid 38444550)
15. Helmy A: Review article: Updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther 2006;23:11-25. (Pubitemid 43381162)
16. Nakano H, Oussoultzoglou E, Rosso E, et al.: Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008;247:118-124.
17. Karoui M, Penna C, Amin-Hashem M, et al.: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7. (Pubitemid 43054046)
18. DeLeve LD, McCuskey RS, Wang X, et al.: Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999;29:1779-1791. (Pubitemid 29247052)
19. DeLeve LD, Wang X, Kanel GC, et al.: Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003;38:900-908. (Pubitemid 37221673)
20. DeLeve LD, Wang X, Tsai J, et al.: Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 2003;125:882-890. (Pubitemid 37070704)
21. Higgins GM, Anderson RM: Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
22. Palmes D, Spiegel H-U: Animal models of liver regeneration. Biomaterials 2004;25:1601-1611. (Pubitemid 38091539)
23. Pastor CM, Wiliams D, Yoneyama T, et al.: Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver. J Biol Chem 1996;271:24534-24538. (Pubitemid 26333190)
24. Taniguchi E, Sakisaka S, Matsuo K, et al.: Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001;49:121-130. (Pubitemid 32012847)
25. Planchamp C, Hadengue A, Stieger B, et al.: Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes. Mol Pharmacol 2007;71:1089-1097. (Pubitemid 46457012)
26. Planchamp C, Gex-Fabry M, Becker CD, et al.: Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers. Invest Radiol 2007;42:513-521. (Pubitemid 46955246)
27. Sorensen BS, Torring N, Bor MV, et al.: The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced. Mol Cell Biochem 2004;260:129-135. (Pubitemid 39127580)
28. Zorzi D, Laurent A, Pawlik TM, et al.: Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274-286. (Pubitemid 46423843)
29. DeLeve LD, Ito Y, Bethea NW, et al.: Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol 2003;284:G1045-G1052. (Pubitemid 36597348)
30. DeLeve LD, Wang X, Hu L, et al.: Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am J Physiol 2004;287:G757-G763. (Pubitemid 39280433)
31. Corpechot C, Barbu V,Wendum D, et al.: Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002;35:1010-1021. (Pubitemid 34453998)
32. Ribero D, Wang H, Donadon M, et al.: Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007;110:2761-2767. (Pubitemid 350250347)
33. Copple BL, Rondelli CM, Maddox JF, et al.: Modes of cell death in rat liver after monocrotaline exposure. Toxicol Sci 2004;77:172-182. (Pubitemid 38128658)
34. Wu YM, Joseph B, Berishvili E, et al.: Hepatocyte transplantation and drug-induced perturbations in liver cell compartments. Hepatology 2008;47:279-287.
35. Nordlinger B, Benoist S: Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 2006;24:4954-4955. (Pubitemid 46631395)
36. Arotcarena R, Cales V, Berthelemy P, et al.: Severe sinusoidal lesions: A serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol 2006;30:1313-1316.
37. Hewes JC, Riddy D, Morris RW, et al.: A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: The effects of prior exposure to chemotherapy. J Hepatol 2006;45:263-270.
38. Aloia T, Sebagh M, Plasse M, et al.: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006;24:4983-4990. (Pubitemid 46631400)
39. Clavien PA, Petrowsky H, DeOliveira ML, et al.: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-1559. (Pubitemid 46588419)